Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
647 studies found for:    osteoporosis AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed PTH Comparison in Post Menopausal Women
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: calcitonin 100 IU/day subcutaneous
22 Terminated A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Condition: Osteoporosis
Interventions: Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
23 Completed Post-menopausal Women Osteoporosis(Phase III)
Condition: Postmenopausal Women Osteoporosis
Interventions: Drug: risedronate combine;   Drug: Risedronate;   Drug: Placebo(for Risedronate);   Drug: Placebo(for risedronate combine)
24 Enrolling by invitation Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX
Condition: Osteoporosis
Intervention:
25 Completed STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
Condition: Postmenopausal Women With Primary Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH)
26 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
27 Completed Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
28 Completed
Has Results
Melatonin Osteoporosis Prevention Study
Conditions: Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: melatonin;   Dietary Supplement: sugar pill
29 Completed
Has Results
Foot Orthoses and Elderly Women With Osteoporosis
Condition: Osteoporosis
Intervention: Device: Foot orthosis (Orthotics Unit of the Clinical Hospital of UNICAMP)
30 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
31 Completed Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: PH3
32 Completed
Has Results
A Study for Patients With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Salmon Calcitonin
33 Completed
Has Results
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Conditions: Menopause;   Osteoporosis
Interventions: Drug: bazedoxifene 20 mg/ conjugated estrogens 0.45 mg;   Drug: bazedoxifene 20 mg/ conjugated estrogens 0.625 mg;   Drug: bazedoxifene 20 mg;   Drug: conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg;   Drug: Placebo
34 Active, not recruiting Teriparatide (PTH) and Bone Strength in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Forteo
35 Completed A Study of Arzoxifene to Treat Korean Women With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: arzoxifene;   Drug: Placebo
36 Terminated Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Interventions: Drug: Alendronate;   Drug: Estrogen/progestin therapy
37 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
38 Completed Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
39 Unknown  Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Test group;   Drug: Reference group
40 Completed Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
Condition: Osteoporosis
Intervention: Drug: AAE581

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years